Ibrunat Ibrutinib 140 mg is an oral targeted therapy used to treat certain blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
| Manufacturer | Natco |
| Generic Name | Ibrutinib |
| Strength | 140 mg |
| Pack size | 30 Capsules |
| Used For | Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |
Ibrukast Ibrutinib 140 mg is an oral targeted therapy used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
| Generic Name | Ibrutinib |
| Strength | 140mg |
| Pack size | 30 Capsules |
| Used For | Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |
